Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation NIHR HSRIC. Crisaborole for adults, adolescents and children with atopic dermatitis. Birmingham: NIHR Horizon Scanning Research&Intelligence Centre. Horizon Scanning Review. 2016 Authors' objectives Atopic dermatitis, also known as eczema, is a long term condition that affects the skin. People with atopic dermatitis have sore, dry skin that causes intense itching, which can ooze and weep. This can lead to skin infections and trouble sleeping. It usually starts in infancy and can sometimes last into adulthood.
Crisaborole is a new anti-inflammatory cream for atopic dermatitis. Some studies have suggested that crisaborole can improve the symptoms of atopic dermatitis. If crisaborole is licensed for use in the UK, it could be a new treatment option for patients with atopic dermatitis. Indexing Status Subject indexing assigned by CRD MeSH Adolescent; Adult; Child; Dermatitis, Atopic; Eczema; Humans; Severity of Illness Index Language Published English Country of organisation England English summary An English language summary is available. Address for correspondence NIHR Horizon Scanning Research&Intelligence Centre, University of Birmingham, Institute of Applied Health Research, Public Health building, Edgbaston, Birmingham B15 2TT
Tel: 0121 414 9077 Email: nihrhsc@contacts.bham.ac.uk AccessionNumber 32016000643 Date abstract record published 19/04/2016 |